XTRA:EVT
XTRA:EVTLife Sciences

Evotec (XTRA:EVT) Valuation Check After Recent Share Price Weakness And AI Platform Growth Hopes

Evotec stock: recent performance snapshot Evotec (XTRA:EVT) has drawn attention after a difficult past 3 months, with the share price showing a negative total return and a similar pattern over the past year, prompting closer scrutiny from investors. See our latest analysis for Evotec. At a share price of €5.51, Evotec has seen short term momentum cool. A 90 day share price return of an 18.71% decline sits alongside a 1 year total shareholder return showing a 35.44% loss. This points to fading...
XTRA:FTK
XTRA:FTKCapital Markets

Will flatexDEGIRO’s Shift to an SE Structure and New COO Recast flatexDEGIRO's (XTRA:FTK) Narrative

In late December 2025, flatexDEGIRO changed its legal form and that of flatexDEGIRO Bank from a German stock corporation (AG) to a Societas Europaea (SE), while also expanding its Group Management Board and appointing long-serving executive Jens Möbitz as Chief Operating Officer from January 1, 2026. This shift to an SE structure, combined with strengthening operational leadership in banking and IT, signals an effort to streamline governance across the group and prepare for the planned...
XTRA:ACT
XTRA:ACTChemicals

3 European Stocks Estimated To Be Trading Below Intrinsic Value In January 2026

As the European markets continue to thrive, with the STOXX Europe 600 Index reaching new highs and closing 2025 with impressive gains, investors are increasingly looking for opportunities within this robust economic environment. In such a context, identifying stocks that may be trading below their intrinsic value can provide potential avenues for growth, particularly when these stocks are supported by strong fundamentals and positive market conditions.
XTRA:MUV2
XTRA:MUV2Insurance

Does Munich Re’s China Leadership Shift Refocus Its Emerging Market Risk Strategy for (XTRA:MUV2)?

Munich Re AG has appointed Eric Zhao as chief executive officer of its Beijing branch, effective January 1, 2026, succeeding Adrian Goh, who moved to become chief risk officer APAC/MEA from February 1, 2026. This leadership reshuffle concentrates regional expertise in both on-the-ground China operations and broader risk oversight, which can influence Munich Re’s approach to growth and risk management across Asian and Middle Eastern markets. We’ll now examine how Eric Zhao’s leadership in...